Related Experiment Video
Updated: Aug 4, 2026
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
Boosting interleukin-10 production: therapeutic effects and mechanisms
Xiaoxia Zhou1, Peter Schmidtke, Fred Zepp
1Paediatric Immunology & Infectious Diseases, University Hospital Mainz, Obere Zahlbacher Str. 63, D-55131 Mainz, Germany. xzhou@uni-mainz.de
Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|December 27, 2005
Summary
Interleukin-10 (IL-10) therapy shows potential for treating inflammatory and autoimmune diseases by suppressing immune responses. Agents that upregulate endogenous IL-10 offer a promising therapeutic strategy for inducing immune tolerance.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Cytokine networks are complex, leading to conflicting results in cytokine-regulating therapies.
- Interleukin-10 (IL-10) is recognized as a potent anti-inflammatory cytokine with significant therapeutic potential.
- IL-10 plays a crucial role in immune regulation, including suppressing inflammatory mediators and promoting immune tolerance.
Purpose of the Study:
- To review observations on interleukin-10 (IL-10) upregulatory therapy.
- To explore the therapeutic effects of IL-10 in various inflammatory and autoimmune diseases.
- To discuss agents that promote endogenous IL-10 production for clinical applications.
Main Methods:
- Review of existing literature on IL-10 upregulatory therapy.
- Analysis of studies investigating IL-10's suppressive effects on immune cells and inflammatory mediators.
- Examination of experimental models and patient data for IL-10-based interventions.
Main Results:
- IL-10 demonstrates a strong suppressive effect on Th1 lymphocytes, antigen-presenting cells, and inflammatory mediator production.
- IL-10 induces antigen-specific regulatory CD4+ T cells, contributing to antigen-specific immune tolerance.
- Various methods, including exogenous administration and endogenous stimulative agents, have been explored for IL-10 therapy.
Conclusions:
- IL-10 upregulatory therapy holds promise for treating inflammatory diseases, autoimmune diseases, and allograft rejection.
- Agents that induce endogenous IL-10 production are a practical approach for sustained therapeutic effects.
- Further research into IL-10 gene regulation and the development of novel upregulatory agents is warranted for advancing immunological disorder treatments.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...